Evidence map›Paper›PMID 21856286›Full record

ArticleBiochemical and biophysical research communications2011

Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.

William M McDougall, Harold C Smith

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

William M McDougallDepartment of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
Harold C Smith
University of Rochester · USUniversity of Rochester Medical Center · US

Funding

Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Discovery of Chemical Probes for RNA-Binding Protein Host Defense FactorsR01GM110119 · NIGMS · OYAGEN, INC. · PI SMITH, HAROLD C · 2015 to 2017
$1.8M
Based deamination by CEM15 suppresses HIV-1 InfectivityR21AI058789 · NIAID · UNIVERSITY OF ROCHESTER · PI SMITH, HAROLD C · 2004 to 2005
$468k
Development of a Novel HIV/AIDS Therapeutic Activating the APOBEC3G Host DefenseR21AI095007 · NIAID · OYAGEN, INC. · PI SMITH, HAROLD C · 2011 to 2012
$462k
NIAID NIH HHS R21 AI058789NIAID NIH HHS R21 AI095007NIGMS NIH HHS R01 GM110119NIGMS NIH HHS T32 GM068411PHS HHS P30 078498PHS HHS R21/R33 076085
6 · The paper itself

Abstract

APOBEC3G (A3G) is a deoxycytidine deaminase active on ssDNA substrates. In HIV infected cells A3G interacted with reverse transcription complexes where its activity as a deoxycytidine deaminase led to mutation of the viral genome. A3G not only bound ssDNA, but it also had an intrinsic ability to bind RNA. In many cell types that can support HIV replication, A3G ssDNA deaminase activity was suppressed and the enzyme resided in high molecular mass, ribonucleoprotein complexes associated with cytoplasmic P-bodies and stress granules. Using a defined in vitro system, we show that RNA alone was sufficient to suppress A3G deaminase activity and did so in an RNA concentration-dependent manner. RNAs of diverse sequences and as short as 25nt were effective inhibitors. Native PAGE analyses showed that RNA formed ribonucleoprotein complexes with A3G and in so doing prevented ssDNA substrates from binding to A3G. The data provided direct evidence that A3G binding to cellular RNAs constituted a substantial impediment to the enzyme's ability to interact with ssDNA.

Indexed as

APOBEC-3G DeaminaseCytidine DeaminaseDNA, Single-StrandedElectrophoretic Mobility Shift AssayHumansRibonucleoproteinsRNASubstrate SpecificityAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseDNA, Single-StrandedRibonucleoproteinsRNA

Identifiers

PMID21856286
PMCPMC3171569
OpenAlexW1977527968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.